The Physiotherapy Assessment of Breathing Pattern Disorder
PHAB
An Evaluation of Physiotherapy Assessment; A Mixed Methods Study to Evaluate the Physiotherapy Assessment of Breathing Pattern Disorder
1 other identifier
observational
150
1 country
1
Brief Summary
This study aims to evaluate a clinical tool called the Breathing Pattern Assessment Tool (BPAT), which is used by physiotherapists to assess breathing pattern disorder (BPD). BPD is a condition where breathing is inefficient or out of sync with the body's needs, leading to symptoms such as breathlessness. The study will investigate whether the BPAT is a reliable and accurate way to identify and assess BPD, and whether it can be used to monitor changes over time, particularly following physiotherapy treatment. It will also compare BPAT scores with other commonly used questionnaires that measure breathlessness and breathing symptoms. Participants will include patients with BPD, patients with asthma, and healthy individuals. Patients with BPD will attend physiotherapy sessions as part of their usual care, during which their breathing will be assessed using the BPAT at different time points, including before and after treatment. Healthy participants will attend a single assessment visit, and asthma participants' data will be collected from routine clinical care. The study will also explore whether BPAT scores change following treatment and whether these changes reflect improvements reported by patients and clinicians. In addition, a small number of patients and physiotherapists will be invited to take part in interviews to share their experiences of the assessment process and treatment. This will help understand whether the BPAT is acceptable and useful in clinical practice. Overall, this study aims to improve how breathing pattern disorder is assessed and monitored, which may help guide better treatment for patients in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2024
CompletedFirst Submitted
Initial submission to the registry
February 11, 2026
CompletedFirst Posted
Study publicly available on registry
April 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedMay 5, 2026
April 1, 2026
1.4 years
February 11, 2026
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Breathing Pattern Assessment Tool BPAT
The Breathing Pattern Assessment Tool (BPAT) is a clinician-completed assessment of breathing pattern. Assessment components include (i) evaluation of chest/abdominal wall movement, noise of (ii) inspiratory and (iii) expiratory flow, (iv) channel of inspiration and expiration, (v) signs of air hunger (yawning, sighing and deeper breaths), (vi) RR and (vii) rhythm. Each component is scored from 0 (normal) to 2 (severely abnormal), with a total score ranging from 0 to 14. Higher scores indicate greater deviation from normal breathing patterns. Changes in score over time reflect changes in breathing pattern.
Baseline for all participants; 4 weeks and through study completion (up to 6 months) for participants with Breathing Pattern Disorder
Secondary Outcomes (7)
Nijmegen Questionnaire
Baseline for all participants; and through study completion (up to 6 months) for participants with Breathing Pattern Disorder
Dyspnoea 12 (D-12) Questionnaire
Baseline for all participants; and through study completion (up to 6 months) for participants with Breathing Pattern Disorder
EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L)
Baseline for all participants; and through study completion (up to 6 months) for participants with Breathing Pattern Disorder
Breath Hold
Baseline for all participants; and through study completion (up to 6 months) for participants with Breathing Pattern Disorder
End Tidal C02
Baseline for all participants; and through study completion (up to 6 months) for participants with Breathing Pattern Disorder
- +2 more secondary outcomes
Study Arms (3)
Breathing Pattern Disorder
Patients referred to physiotherapy with a Breathing Pattern Disorder
Healthy Control
Patients with no respiratory symptoms or disorders
Asthma
Patients diagnosed with asthma but no concerns for breathing pattern disorder
Interventions
Patients who have Breathing Pattern Disorder will be assessed with the Breathing Pattern Assessment Tool and then will undergo Physiotherapy intervention. This includes up to 4 sessions of physiotherapy treatments which include biomechanical, biochemical and psychopathological interventions for breathing pattern
Eligibility Criteria
Patients with BPD (n=100) A convenience sample of patients referred to physiotherapy outpatient services of Royal Brompton Hospitals for BPD or unexplained breathlessness, over a 22-month recruitment period will be recruited. Healthy control (n=25) A convenience sample of healthy controls will be recruited from relative/significant other accompanying the study participant and/or hospital staff. Asthma control patients (n=25) Patients will be recruited from the Systematic Assessment of Asthma Clinic and data used from their completed usual care assessment.
You may qualify if:
- Adults aged above 18 years
- Outpatient referrals for 'unexplained breathlessness' or possible breathing pattern disorder
- Primary BPD (no other significant respiratory or cardiology diagnosis)
- Secondary BPD (patients with a diagnosis of asthma)
You may not qualify if:
- Patients with a respiratory diagnosis including COPD, ILD, Bronchiectasis and Cystic Fibrosis or structural heart disease
- Pregnancy
- Unable to give informed consent
- Anyone currently participating in pulmonary/cardiac rehabilitation
- Anyone receiving specialist ENT speech and language therapy for Upper airway symptoms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Brompton Hospital
London, London, SW3 6NP, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lizzie JF Grillo, BSc MSc
Royal Brompton and Harefield Hospital
Central Study Contacts
Lizzie Grillo JF Clinical Specialist Physiotherapist, BSc MSc
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Advanced Physiotherapist
Study Record Dates
First Submitted
February 11, 2026
First Posted
April 22, 2026
Study Start
December 10, 2024
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Start: 6 months after publication of primary results. End: Indefinitely
- Access Criteria
- Qualified researchers may request access to de-identified individual participant data. Requests will be reviewed by the study investigators. Approved data will be shared via a secure online repository or by direct data transfer. Data will be limited to de-identified datasets necessary to reproduce the reported analyses.
De-identified individual participant data underlying the results reported in publications, including baseline characteristics, outcome measures, and relevant covariates. All direct identifiers will be removed prior to sharing. Data will be made available for the IPD that underlie results in a publication. This will be available within the publication and anonymous data available on online repository